Biotech’s Rare-Disease Darling Returns as FDA Hard-Liners Depart
Investor confidence surges in rare-disease biotech as the FDA’s strict regulatory stance softens, paving the way for renewed investment and accelerated drug development.
Investor confidence surges in rare-disease biotech as the FDA’s strict regulatory stance softens, paving the way for renewed investment and accelerated drug development.
European indexes climbed today, driven by a strong recovery in bank and AI stocks that are recouping recent losses.
Geopolitical tensions in the Middle East continue to exert upward pressure on oil prices, keeping them elevated above $100 a barrel despite minor declines in early trading.
The 10-year Treasury yield has surpassed 5%, reaching a post-financial crisis high and signaling a potential new era of higher borrowing costs.
Nvidia’s strong performance is driving a TMT sector rally, with BCE and FedEx also capturing investor interest.
Hot weather is driving U.S. natural gas futures higher due to increased cooling demand.
Stock futures fall amid rising oil prices and persistent 5% Treasury yield as investors await the Federal Reserve’s decision.
BlackRock Investment Institute believes equities remain attractive even as global interest rates climb.
U.S. Treasury yield surge triggers Singapore dollar depreciation.
Stocks plummeted amid AI development slowdown calls and rising oil prices sparking interest rate hike fears.